Control Population

OTHER3 trials

Sponsors

Beth Israel Medical Center, Stop TB Partnership hosted by UNOPS

Conditions

Aplastic AnaemiaChemotherapy Induced ThrombocytopeniaImmune ThrombocytopeniaMyelodysplasiaTuberculosis

Unknown Phase

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

CompletedNCT01933035

Beth Israel Medical CenterAplastic Anaemia, Chemotherapy Induced Thrombocytopenia, Immune Thrombocytopenia +1

Start: 2013-10-31End: 2015-10-31Updated: 2016-05-17

Evaluating the effect of interventions for decentralized Drug-Resistant Tuberculosis services, and contextual factors that influenced its implementation in 2 southern Nigerian states: A Quasi-experimental study

Active, not recruitingPACTR202309676675265

Stop TB Partnership hosted by UNOPSTuberculosis

Start: 2022-04-01Target: 483Updated: 2026-08-03

Expanding Coverage and Access to Person-centred Quality TB and Mental Health Care through Integrated Service Delivery in Nigeria

RecruitingPACTR202501828312848

Stop TB Partnership hosted by UNOPSTuberculosis

Start: 2023-07-01Target: 7642Updated: 2026-08-03

Related Papers

Enhancing programmatic scale-up: Applying the consolidated framework for implementation research to evaluate decentralized drug-resistant tuberculosis services in Southern Nigeria

PLoS ONE2025-02-21